Column Group IV, LP, 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 153,754 shares at $4.86 ($747K) on 2022-10-27, disclosed to the SEC on 2022-10-31.
Open-market purchase of $747k NGM by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.86 | 76,877 | $374K | 50.0% |
| 2 | $4.86 | 76,877 | $374K | 50.0% |
| Total | $4.86 avg | 153,754 | $747K | 100% |
| Filing → |
| NGM | BUY | 2022-05-17 | $842K | — | Filing → |